摩根士丹利因增长前景将龙沙集团股票评级上调至增持 - Investing.com 印度版
Morgan Stanley upgrades Lonza Group stock to Overweight on growth outlook - Investing.com India
#Lonza Group#Investing.com India#Morgan Stanley#Stanley upgrades#upgrades Lonza
生命科学资讯
生物技术与制药领域的最新动态
微尺寸与Schedio集团收购龙沙集团位于瑞士的微粉化生产基地——贝克斯菲尔德.com报道
Microsize und Schedio Group übernehmen Lonzas Standort Micro-Macinazione in der Schweiz - Bakersfield.com
#Schedio Group#Lonzas Standort#und Schedio#Group übernehmen#übernehmen Lonzas
微尺寸与Schedio集团将收购龙沙在瑞士的微粉化工厂——商业电讯
Microsize and Schedio Group to Acquire Lonza’s Micro-Macinazione Site in Switzerland - Business Wire
Microsize与Schedio集团将收购龙沙集团位于瑞士的微粉化工厂——雅虎财经澳大利亚报道
Microsize and Schedio Group to Acquire Lonza’s Micro-Macinazione Site in Switzerland - Yahoo Finance Australia
#Schedio Group#Acquire Lonza#Yahoo Finance#Finance Australia#Micro-Macinazione Site
交易快讯：雅培、TPG与龙沙集团大举行动，M&M乳业及新堡垒能源遇挫——Benzinga报道
Deal Dispatch: Abbott, TPG And Lonza Make Major Moves, M&M Custard And New Fortress Energy Struggle - Benzinga
#Major Moves#Lonza Make#Make Major#Fortress Energy#Energy Struggle
基因疗法细胞培养基市场主要企业——龙沙公司 - openPR.com
Gene Therapy Cell Culture Media Market By Top Companies-Lonza - openPR.com
#Therapy Cell#Cell Culture#Culture Media#Media Market#Gene Therapy
瑞士龙沙集团拟以25亿欧元出售部分资产——AKM.RU报道
Swiss Lonza Group plans to sell part of assets for 2.5 billion euros - AKM.RU
#Lonza Group#Swiss Lonza#Group plans#billion euros#sell part
为何Lonza集团（普通股）LO3A可能成为2025年最大赢家——关键催化剂与聪明资金动向警示
Why Lonza Group AG (Common Stock) (LO3A) stock could be top winner - 2025 Major Catalysts & Smart Money Movement Alerts - newser.com
#Major Catalysts#Smart Money#Lonza Group#Money Movement#Common Stock
朗峰集团周五下跌，表现逊于大盘 - 富途牛牛
Lonza Group AG Falls Friday, Underperforms Market - 富途牛牛
#Falls Friday#Underperforms Market#Lonza Group#Friday#Underperforms
Lonza集团普通股(LO3A)能否超越营收预期——聚焦美元强势与资本效率的新思
Will Lonza Group AG (Common Stock) (LO3A) stock beat revenue estimates - Dollar Strength & Capital Efficiency Focused Ideas - newser.com
#Dollar Strength#Capital Efficiency#Lonza Group#Efficiency Focused#Common Stock
彭博社：孤星、阿尔塔里斯与One Rock竞购龙沙资产
Lone Star, Altaris, One Rock Said Among Bidders for Lonza Assets - Bloomberg.com
#Lone Star#Lonza Assets#Assets Bloomberg.com#Altaris#Bloomberg.com Lone
隆萨集团普通股(LO3A)对美元走强的反应——投资组合风险报告与免费长期投资增长策略 - 新闻网站报道
How Lonza Group AG (Common Stock) (LO3A) stock reacts to stronger dollar - Portfolio Risk Report & Free Long-Term Investment Growth Plans - newser.com
#Portfolio Risk#Risk Report#Lonza Group#Investment Growth#Common Stock
龙沙集团拟收购红莓科技，扩大生物科学测试业务——技术网络
Lonza To Expand Bioscience Testing With Acquisition of Redberry - Technology Networks
#Expand Bioscience#Bioscience Testing#Technology Networks#Redberry Technology#Networks Lonza
图森新闻：朗扎·亨德森小队长专访——KOLD频道
Captain Lonza Henderson Jr. TUCSON NOW Interview - KOLD
#Lonza Henderson#Captain Lonza#Lonza#Henderson#TUCSON
监管、cGMP与CDMO挑战：CPHI与龙沙胶囊对话录（下篇）——PharmTech.com
Regulatory, cGMP, and CDMO Challenges: A CPHI Conversation with Lonza Capsugel, Part Two - PharmTech.com
#CDMO Challenges#Lonza Capsugel#CPHI Conversation#cGMP#Challenges
利用龙沙先进技术解决配方难题——营养保健品商业评论
Solving formulation challenges with Lonza’s advanced technologies - Nutraceutical Business Review
#Nutraceutical Business#Business Review#Solving formulation#formulation challenges#Review Solving
龙沙生物科学负责人谈近期收购红莓公司——国际生物工艺
Lonza head of bioscience talks recent Redberry acquisition - BioProcess International
龙沙集团收购Redberry，扩大生物科学检测服务范围——精选科学报道
Lonza to expand bioscience testing offering with the acquisition of Redberry - SelectScience
#expand bioscience#bioscience testing#testing offering#Redberry SelectScience#SelectScience Lonza
剂型创新：与龙沙Frank Romanski在CPHI法兰克福的对话（上篇）——PharmTech.com
Dosage Form Innovations: A CPHI Frankfurt Conversation with Lonza’s Frank Romanski, Part One - PharmTech.com
#Form Innovations#Frank Romanski#CPHI Frankfurt#Frankfurt Conversation#Dosage Form
混合基本面是否会对龙沙集团（VTX:LONN）当前股价走势产生负面影响？- 雅虎财经
Can Mixed Fundamentals Have A Negative Impact on Lonza Group AG (VTX:LONN) Current Share Price Momentum? - Yahoo Finance
#Current Share#Price Momentum#Mixed Fundamentals#Negative Impact#Lonza Group